- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
OLYMPIA, WA - Yesterday the Washington State Senate concurred on House amendments to Senate Bill 5052, which regulates medical cannabis. SB 5052 has now passed through the full Washington legislature meaning that the bill will now be sent to Governor Inslee’s desk. Given the final language of the bill the best course of action is for Governor Inslee to protect patients by using his veto powers.
While legislative solutions that would have addressed well-documented concerns from medical cannabis patients, health care professionals, compassionate designated providers, and those in the industry exist, they have been not been incorporated into the bill’s language.
“As it stands, SB 5052 contains a number of sections that would undermine the ability of patients to maintain their access to a steady supply of essential cannabis products,” said Steph Sherer, executive director of Americans for Safe Access. “These extreme restrictions mean the end of medical cannabis in Washington in the way that patients have come to rely on.”
A number of problematic sections reach beyond the needed regulations and severely undermine the doctor-patient relationship, create undue and arbitrary limitations on the amount of cannabis patients can possess and creates confusion about whether a patient database is voluntary or not. At a minimum Governor Inslee should veto the emergency clause in Section 51 of the bill to allow for additional time for planning and implementation of this complex legislation.
April 14th ASA letter to Governor Inslee calling for Veto: